-

Shareholder Alert: Robbins LLP Announces Phoenix Tree Holdings, Ltd. (DNK) Sued for Misleading Shareholders

SAN DIEGO & DONGCHENG DISTRICT, Beijing--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Phoenix Tree Holdings, Ltd. (NASDAQ: DNK) filed a class action complaint against the Company for alleged violations of the Securities Act of 1933 pursuant to the company's January 2020 initial public offering ("IPO"). Phoenix is a Cayman Islands holding company that leases and manages apartments in China.

If you suffered a loss as a result of Phoenix's misconduct, click here.

Phoenix Tree Holdings, Ltd. (DNK) Accused of Misleading Shareholders

According to the complaint, Phoenix held its IPO on January 22, 2020, offering approximately 9.6 million ADSs at $13.50 per share for gross proceeds of approximately $128.4 million. In its offering materials, Phoenix touted the Company's focus on residents and customer service as well as its use of data-driven technology to effectively compete in the market. The offering materials also recognized the adverse effects complaints from residents and the highly competitive residential rental market could have on its business. However, Phoenix failed to disclose that by the time of the IPO it was already (i) the subject of numerous complaints from tenants for questionable conduct, including deceptively inducing renters to procure loans whose proceeds financed the Company's business operations, and (ii) suffering from the coronavirus pandemic's impact on the residential rental market. On March 25, 2020, Phoenix announced its unaudited financial results for fourth quarter and fiscal year 2019, revealing that it expected coronavirus to adversely affect its financial performance for first quarter of 2020. Phoenix's ADSs currently trade at around $7 per share, representing a 48% decline from its IPO price.

Phoenix Tree Holdings, Ltd. (DNK) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:DNK

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom